~315 spots leftby Feb 2027

Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer

Recruiting in Palo Alto (17 mi)
JA
Overseen byJose A Rauh-Hain
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: M.D. Anderson Cancer Center
No Placebo Group

Trial Summary

What is the purpose of this trial?

This study develops infertility survey among reproductive age women with gynecological and breast cancer. This study aims to learn how women consider whether or not to try to have a baby after surviving cancer. The advice gathered from this survey may be shared with patients and survivors in the future, so that they have information to inform their decisions about cancer treatment and family planning.

Research Team

JA

Jose A Rauh-Hain

Principal Investigator

M.D. Anderson Cancer Center

Eligibility Criteria

Inclusion Criteria

FOCUS GROUP: Women seen at the MD Anderson Oncofertility Clinic and Adolescent and Young Adult Program who are 18-45 years old at the time of cancer diagnosis
SURVEY VALIDATION: Women seen at the MD Anderson Oncofertility Clinic and Adolescent and Young Adult Program who are 18-45 years old at the time of cancer diagnosis
TELEPHONE SURVEY: Women in the California Cancer Registry
See 4 more

Treatment Details

Interventions

  • Healthcare Activity (Behavioral Intervention)
  • Survey Administration (Other)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Observational (focus group, survey)Experimental Treatment2 Interventions
FOCUS GROUP: Patients attend an audiotaped focus group over 90 minutes to provide feedback for survey development. SURVEY VALIDATION: Patients complete an online survey over 15-30 minutes at baseline and 2 days later. TELEPHONE SURVEY: Patients complete a telephone survey.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3107
Patients Recruited
1,813,000+